VolitionRx Limited (VNRX)
VolitionRx Statistics
Share Statistics
VolitionRx has 100.78M shares outstanding. The number of shares has increased by 15.72% in one year.
| Shares Outstanding | 100.78M |
| Shares Change (YoY) | 15.72% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 21.27% |
| Shares Floating | 74.62M |
| Failed to Deliver (FTD) Shares | 2.5K |
| FTD / Avg. Volume | 1.4% |
Short Selling Information
The latest short interest is 495.4K, so 0.5% of the outstanding shares have been sold short.
| Short Interest | 495.4K |
| Short % of Shares Out | 0.5% |
| Short % of Float | 0.63% |
| Short Ratio (days to cover) | 1.29 |
Valuation Ratios
The PE ratio is -1.93 and the forward PE ratio is -12.05. VolitionRx's PEG ratio is 0.05.
| PE Ratio | -1.93 |
| Forward PE | -12.05 |
| PS Ratio | 42.09 |
| Forward PS | 0.2 |
| PB Ratio | -2.08 |
| P/FCF Ratio | -1.98 |
| PEG Ratio | 0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for VolitionRx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of -0.07.
| Current Ratio | 0.52 |
| Quick Ratio | 0.52 |
| Debt / Equity | -0.07 |
| Debt / EBITDA | -0.07 |
| Debt / FCF | -0.07 |
| Interest Coverage | -79.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $14.51K |
| Profits Per Employee | $-317.27K |
| Employee Count | 85 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -44.21% in the last 52 weeks. The beta is 1.16, so VolitionRx's price volatility has been higher than the market average.
| Beta | 1.16 |
| 52-Week Price Change | -44.21% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 45.94 |
| Average Volume (20 Days) | 179.13K |
Income Statement
In the last 12 months, VolitionRx had revenue of 1.23M and earned -26.97M in profits. Earnings per share was -0.31.
| Revenue | 1.23M |
| Gross Profit | 1.23M |
| Operating Income | -27.02M |
| Net Income | -26.97M |
| EBITDA | -25.58M |
| EBIT | -26.92M |
| Earnings Per Share (EPS) | -0.31 |
Balance Sheet
The company has 3.26M in cash and 1.87M in debt, giving a net cash position of 1.4M.
| Cash & Cash Equivalents | 3.26M |
| Total Debt | 1.87M |
| Net Cash | 1.4M |
| Retained Earnings | -229.54M |
| Total Assets | 9.4M |
| Working Capital | -3.73M |
Cash Flow
In the last 12 months, operating cash flow was -25.89M and capital expenditures -277.5K, giving a free cash flow of -26.17M.
| Operating Cash Flow | -25.89M |
| Capital Expenditures | -277.5K |
| Free Cash Flow | -26.17M |
| FCF Per Share | -0.3 |
Margins
Gross margin is 100%, with operating and profit margins of -2190.9% and -2186.27%.
| Gross Margin | 100% |
| Operating Margin | -2190.9% |
| Pretax Margin | -2186.27% |
| Profit Margin | -2186.27% |
| EBITDA Margin | -2073.65% |
| EBIT Margin | -2190.9% |
| FCF Margin | -2121.68% |
Dividends & Yields
VNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VNRX is $3.75, which is 665.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.75 |
| Price Target Difference | 665.3% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -43.2 |
| Piotroski F-Score | 3 |